These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7707321)

  • 1. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Ford H; Siddiqui MA; Driscoll JS; Marquez VE; Kelley JA; Mitsuya H; Shirasaka T
    J Med Chem; 1995 Mar; 38(7):1189-95. PubMed ID: 7707321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Driscoll JS; Siddiqui MA; Ford H; Kelley JA; Roth JS; Mitsuya H; Tanaka M; Marquez VE
    J Med Chem; 1996 Apr; 39(8):1619-25. PubMed ID: 8648601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the mechanism of enhancement of central nervous system delivery of 2'-beta-fluoro-2',3'-dideoxyinosine via a blood-brain barrier adenosine deaminase-activated prodrug.
    Johnson MD; Chen J; Anderson BD
    Drug Metab Dispos; 2002 Feb; 30(2):191-8. PubMed ID: 11792690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
    Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H
    J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
    Morgan ME; Chi SC; Murakami K; Mitsuya H; Anderson BD
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2156-65. PubMed ID: 1444295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs.
    Barchi JJ; Marquez VE; Driscoll JS; Ford H; Mitsuya H; Shirasaka T; Aoki S; Kelley JA
    J Med Chem; 1991 May; 34(5):1647-55. PubMed ID: 2033591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)hypoxanthine.
    Liaw YC; Gao YG; Marquez VE; Wang AH
    Nucleic Acids Res; 1992 Feb; 20(3):459-65. PubMed ID: 1741280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.
    Shanmuganathan K; Koudriakova T; Nampalli S; Du J; Gallo JM; Schinazi RF; Chu CK
    J Med Chem; 1994 Mar; 37(6):821-7. PubMed ID: 8145233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C; Knispel T; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
    Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
    Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
    Siddiqui MA; Driscoll JS; Marquez VE; Roth JS; Shirasaka T; Mitsuya H; Barchi JJ; Kelley JA
    J Med Chem; 1992 Jun; 35(12):2195-201. PubMed ID: 1351945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.
    Shirasaka T; Murakami K; Ford H; Kelley JA; Yoshioka H; Kojima E; Aoki S; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9426-30. PubMed ID: 2251284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic targeting of anti-HIV nucleosides: distribution of 2',3'-dideoxyinosine after intravenous and oral administration of dipalmitoylphosphatidyl prodrug in mice.
    Manouilov KK; Xu ZS; Boudinot FD; Schinazi RF; Chu CK
    Antiviral Res; 1997 May; 34(3):91-9. PubMed ID: 9191016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.